Exhaled inflammatory markers in aspirin-induced asthma syndrome

American Journal of Rhinology

Volumn 21, Issue 5, 2007, Pages 542-547

  Carpagnano, Giovanna Elisiana ^a,d   Resta, Onofrio ^b   Gelardi, Matteo ^b   Spanevello, Antonio ^c   Di Gioia, Giuseppe ^c   Giliberti, Tiziana ^c   Depalo, Annarita ^a   Barbaro, Maria P Foschino ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c IRCCS   (Italy)

^d NONE   (Italy)

Author keywords

AERD; AIA syndrome; Airways inflammation; Asthma; Breath condensate; Eosinophils; Interleukins; Markers; Nasal polyposis; Neutrophils

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 6;

ADULT; ARTICLE; ASPIRIN INDUCED ASTHMA; ASTHMA; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; ENZYME IMMUNOASSAY; EOSINOPHIL; EXPIRED AIR; FEMALE; HUMAN; MALE; NEUTROPHIL; NOSE POLYP; PATHOGENESIS; RESPIRATORY TRACT INFLAMMATION;

ADULT; ASPIRIN; ASTHMA; BIOLOGICAL MARKERS; EOSINOPHILS; EXHALATION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-4; INTERLEUKIN-6; LUNG; MALE; MIDDLE AGED; NEUTROPHILS; RESPIRATION; SKIN TESTS; SYNDROME;

EID: 36048941013     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.3066     Document Type: Article

References (37)

1. Jenkins C, Costello J, and Hodge L. Systematic review of prevalence of aspirin induced asthma and its implication for clinical practice. BM J 328:434, 2004.
2. Widal F, Abrami P, and Lermoyez J. Anaphylaxie et idiosyncrasie. Press Med 30:189-193, 1922.
3. Meikle D. Aspirine sensitivity and recurrent polyposis. Clin Otalaryngol 13:1-3, 1988.
4. Sanak M, Simon HU, and Szczeklin A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350:1599-1600, 1997.
5. Pods R, Ross D, van Hudie;lst S, et al. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad. Allergy 58:1165-1170, 2003.
6. Babu KS, and Salvi SS. Aspirine and asthma. Chest 118:1470-1476, 2000.
7. Di Lorenzo G, Drago A, Esposito Pellitteri M, et al. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Int Arch Allergy Immunol 125:164-175, 2001.
8. Zhang N, Holtappels G, Claeys C, et al. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 4:445-450, 2006.
9. Meyer JE, Bartels J, Görögh T, et al. The Role of RANTES in nasal polyposis. Am J Rhinol 19:15-20, 2005.
10. Larsen K. The clinical relationship of nasal polyps and asthma. Allergy Asthma Proc 17:243-249, 1996.
11. Kowalski ML, Grzegorczyk J, Pawliczak R, et al. Decreased apoptosis and distinct profile of infiltrating cells in nasal polyps with ASA hypersensibility. Allergy 57:493-500, 2002.
12. Stevenson DD, and Zuraw BL. Pathogenesis of aspirin exacerbated respiratory disease. Clin Rev Allergy Immunol 24:169, 2003.
13. Share SA, Austen KF, and Drazen JM. Eicosanoids and the Lung. In Lung cell biology: Lung biology in health and disease. L'Enfant C, and Massaro D (Eds). New York: Marcel Dekker, Inc., 1989.
14. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 149:940-946, 1994.
15. Obase Y, Shimoda T, Tomari SY, et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest 121:143-150, 2002.
16. 4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 167:1109-1112, 2003.
17. Lamblin C, Gosset P, Salez F, et al. Eosinophilic airway inflammation in nasal polyposis. J Allergy Clin Immunol 104:85-92, 1999.
18. Gwaltney JM Jr, Jones JG, and Kennedy DW. Medical management of sinusitis: Educational goals and management guidelines. The International Conference on sinus Disease. Ann Otol Rhinol Laryngol Suppl 167:22-30, 1995.
19. Von Mutius E. Presentation of new GINA guidelines for pediatrics. The Global Initiative on asthma. Clin Exp Allergy 30(suppl 1):6-10, 2000.
20. Bianco S, Robuschi M, and Petrigni G. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test. J Med Sci 5:129-130, 1977.
21. Dreborg S, and Frew A. Position paper: Allergen standardization and skin tests. Allergy 48:49-82, 1993.
22. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 6(suppl 16):53-83, 1993.
23. Lee HS, Majima Y, Sakakura Y, et al. Quantitative cytology of nasal secretions under various conditions. Laringoscopie 103:533-537, 1993.
24. Meltzer E, and Jalowayski A. Nasal cytology in clinical practice. Am J Rhinol 2:47-54, 1988.
25. Bland JM, and Airman DG. Statistics notes: Measurement error. BMJ 313:744, 1996.
26. Kramer MF, and Rasp G. Nasal polyposis: Eosinophils and interleukin-5. Allergy 54:669-689, 1999.
27. Carpagnano GE, Foschino Barbara MP, Resta O, et al. Exhaled markers in the monitoring of airways inflammation and its responses to steroid's treatment in mild persistent asthma. Eur J Pain 519:175-181, 2005.
28. Bachert C, Gevaert P, Holtappels G, and van Cauwenberge P. Mediators in nasal polyposis. Curr Allergy Asthma Rep 2:481-487, 2002.
29. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 21:589-593, 2003.
30. Szczeklik A, and Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis and management. J Allergy Clin Immunol 104:5-13, 1999.
31. Akpinarli A, Guc D, Kalayci O, et al. Increased interleukin-4 and decreased interferon gamma production in children with asthma: Function of atopy or asthma? J Asthma 39:159-165, 2002.
32. Stankiewicz W, Dabrowski MP, Chcialowski A, and Plusa T. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. Mediators Inflamm 11:307-312, 2002.
33. Wong CK, Ho CY, Ko FW, et al. Proinflammatory cytokines [IL-17, IL-6, IL-18, IL-12] and Th-cytokines (INF-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125:177-183, 2001.
34. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus non allergic chronic sinusitis. J Allergy Clin Immunol 96:537-544, 1995.
35. Zhao XJ, McKerr G, Dong Z, et al. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax 56:205-211, 2001.
36. Ediger D, Sin BA, Heper A, et al. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma. Clin Exp Allergy 35:319-326, 2005.
37. Sanak M, Kielbasa B, Bochenek G, and Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy 34:1899-1904, 2004.